Consensus STERIS plc

Equities

STE

IE00BFY8C754

Market Closed - Nyse 04:00:02 2024-04-24 pm EDT 5-day change 1st Jan Change
202.8 USD -1.55% Intraday chart for STERIS plc +1.28% -7.76%

Evolution of the average Target Price on STERIS plc

Price target over the last 5 years

History of analyst recommendation changes

9415a0ec81f61a3e7b1f4181bf.uVvPiz8zxzTyTtUPE0aW18CIJRu8lXlLHoJ_HhNP4kI.3Smk7k0CrQKjPr9YVxbXlJO4aWLf-iYNKbQRcXAmlwDeKp7Fblq1Ap4DmA~6899298c8c5c8127c38aa2951442880a
Wolfe Research Adjusts STERIS Price Target to $235 From $245 MT
Morgan Stanley Cuts Price Target on STERIS to $215 From $225, Keeps Equalweight Rating MT
ANALYST RECOMMENDATIONS : Biogen, Conocophillips, Kellanova, Take Two, Tesla... Our Logo
Piper Sandler Adjusts Price Target on STERIS to $215 From $220, Maintains Neutral Rating MT
All hail the resilience of the US economy Our Logo
ANALYST RECOMMENDATIONS : Adobe, Live Nation, Meta, Snap, Wpp... Our Logo
JMP Securities Adjusts STERIS' Price Target to $265 From $240, Keeps Market Outperform Rating MT
Morgan Stanley Adjusts Price Target on STERIS to $225 From $206, Maintains Equalweight Rating MT
KeyBanc Adjusts Price Target on STERIS to $258 From $254, Maintains Overweight Rating MT
KeyBanc Lifts Price Target on STERIS to $254 From $235, Says Initial Guidance 'Likely Conservative,' Keeps Overweight Rating MT
Stephens Adjusts STERIS' Price Target to $250 From $240, Keeps Overweight Rating MT
Morgan Stanley Initiates Coverage on STERIS With Equal Weight Rating, $206 Price Target MT
Piper Sandler Adjusts Price Target on STERIS to $200 From $197, Keeps Neutral Rating MT
Keybanc Adjusts Price Target on STERIS to $235 From $210, Keeps Overweight Rating MT
Piper Sandler Downgrades STERIS to Neutral From Overweight, Adjusts Price Target to $197 From $215 MT
Piper Sandler Cuts Price Target on STERIS to $215 From $235, Maintains Overweight Rating MT
KeyBanc Adjusts STERIS' Price Target to $210 From $240, Keeps Overweight Rating MT
Needham Downgrades STERIS to Hold From Buy on Capital Equipment Exposure, Potential Ethylene Oxide Liabilities; $237 Price Target Removed MT
KeyBanc Adjusts STERIS' Price Target to $240 From $256, Reiterates Overweight Rating MT
Piper Sandler Adjusts STERIS' Price Target to $235 From $240, Reiterates Overweight Rating MT
Needham Cuts STERIS' Price Target to $237 From $248 Following FY Guidance Cut, Reiterates Buy Rating MT
Piper Sandler Starts STERIS at Overweight With $240 Price Target MT
Needham Lowers Price Target for STERIS to $248 From $263, Maintains Buy Rating MT
Wolfe Research Starts STERIS at Outperform With $275 Price Target MT
Fitch Affirms STERIS plc Issuer Default Rating at 'BBB'; Outlook Stable AQ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
202.8 USD
Average target price
239.9 USD
Spread / Average Target
+18.27%
High Price Target
265 USD
Spread / Highest target
+30.67%
Low Price Target
215 USD
Spread / Lowest Target
+6.02%

Consensus detail

Consensus revision (last 18 months)

Analysts covering STERIS plc

Wolfe Research
Morgan Stanley
Piper Sandler
JMP Securities
KeyBanc Capital Markets
Stephens Inc.
Needham & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings